Skip to main content
Premium Trial:

Request an Annual Quote

MorphoSys Gets $1.4M to Develop Cancer Program, Explore Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –MorphoSys said today that it has received a €1.1 million ($1.4 million) grant to accelerate development of its cancer program.

The grant from the German Federal Ministry of Education and Research specifically will be used to develop the company's HuCAL-based cancer program MOR202 into clinical development for treating multiple myeloma. As part of the effort, the company will explore relevant biomarkers for the anti-CD38 approach in collaboration with the university hospital of Munich Technical University, MorphoSys said in a statement.

MOR202 is a fully human, HuCAL antibody directed against CD38, a membrane-bound glycoprotein that maybe a therapeutic target for the treatment of multiple myeloma and certain leukemias. In a statement, MophoSys' Chief Development Officer Arndt Schottelius said that the incorporation of biomarkers into the new therapeutic approach further differentiates the company's program.

"This grant supports the MOR202 program, for which we are on track to file a clinical trial application in Europe before the end of 2010," he said.

Based in Martinsried/Munich, MorphoSys focuses on fully human antibodies for the diagnoses and treatment of diseases and for research.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.